StonvexLoading…
StonvexStonvexStonvexCore line items from ONC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.51B | $5.34B | $3.84B | $2.43B |
Operating Income | $249.90M | $447.14M | $262.10M | $98.99M |
Net Income | $227.36M | $286.93M | $220.43M | $94.32M |
EPS (Diluted) | $0.15 | $0.19 | $0.15 | $0.07 |
Total Assets | $8.55B | $8.19B | $7.63B | $6.30B |
Total Liabilities | $3.79B | $3.83B | $3.50B | $2.53B |
Cash & Equivalents | $4.79B | $4.55B | $4.04B | $2.76B |
Free Cash Flow OCF − CapEx | $160.55M | $941.74M | $561.92M | $207.45M |
Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.43B |